ThermoGenesis Corp. (NASDAQ: KOOL) has their focus on the regenerative medicine market. This focus inspired the company to create a wholly-owned subsidiary named Vantus Inc. This subsidiary is a veterinary stem cell laboratory service that has collaborations with the UC Davis School of Veterinary Medicine’s Center for Equine Health and its Stem Cell Regenerative Medicine group to conduct research and development to enhance the collecting, processing, and storing of stem cells. For further information, visit the Company’s web site at www.thermogenesis.com.
- 16 years ago
QualityStocks
ThermoGenesis Corp. (NASDAQ: KOOL)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – AirJoule Technologies Corporation (NASDAQ: AIRJ) Secures $15 Million Private Placement Led by GE Vernova
AirJoule Technologies (NASDAQ: AIRJ) announced it has entered into subscription agreements for a $15 million…
-
QualityStocksNewsBreaks – BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXZ) (TSX: BCT) Prices $13.8 Million Public Offering
BriaCell Therapeutics (Nasdaq: BCTX, BCTXZ) (TSX: BCT) announced the pricing of an underwritten public offering…
-
Nightfood Holdings Inc. (NGTF) Accelerates Growth Through Strategic Acquisitions in AI-Driven Hospitality, Hotel Management
Report notes that the increasing pace of transactions serves as an encouraging sign for the…